GUTSFractyl Health, Inc. Common Stock

$35M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5,000

Gross Profit

$2,00040.0% margin

Operating Income

-$12M-242140.0% margin

Net Income

-$12M-238640.0% margin

EPS (Diluted)

$-0.25

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$857,000

Balance Sheet

Total Assets

$0

Total Liabilities

$0

Stockholders' Equity

$0

Cash & Equivalents

$0

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5,000	$0	—
Gross Profit	$2,000	$0	—
Operating Income	-$12M	-$13M	+8.3%
Net Income	-$12M	-$12M	+2.7%

GUTS Q1 2023 Earnings — Fractyl Health, Inc. Common Stock Revenue & Financial Results | Market Cap Arena